CAR-T, page-10

Keep in mind a $1 sp for PTX equates to a market cap of only about $600m due to so few shares on issue, atleast for a biotech company at any rate.

Will completely come down to the data & we are expecting a lot of it this year, some of which should be fairly mature/significant enough to potentially push us over the billion market cap so could be closet to $2.

Look at your favourite IMU...Raced from $200m to almost $3 billion market cap...These companies move quickly on the right data.

PTX-100 expanded cohort readout will be enough to give the market a fairly clear indication of if it will move to production after a registrational trial...Good data will mean many multiples of the current market cap imo.

Then you have OmniCar Car-T platform moving close to phase 1 trials...Again a lot of potential for significant value add.

A few dollars sp with our SOI is very realistic with our expected news pipeline...But we must get the desired data at the end of the day so it's a wait and watch.

Cheers.